Logo Rabies Vaccine BP

RABIES VACCINE BP® OVERVIEW

Rabies Vaccine BP is an inactivated vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies in all age groups.

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

Rabies Vaccine BP Prescribing information

View the Rabies Vaccine BP SmPC

Why help protect your patients with Rabies Vaccine BP?

Rabies is an acute viral infection causing inflammation of the spinal cord and the brain1 that leads to the deaths of tens of thousands of people worldwide.2 In developing countries, where it is most often transmitted by dogs, rabies is still considered a major public health concern.2

Transmitted through the saliva of an infected mammal, usually via a bite, scratch or lick3 The incubation period for the disease is usually 2-3 months but can be anything from a week to 1 year.2

Vaccination may be considered for all travellers who will be living or visiting endemic areas especially if:3

  • visiting areas where access to post-exposure treatment and medical care is limited

  • they are planning higher risk activities such as cycling and running

  • they are planning to stay for more than one month


Rabies Vaccine BP can be used to help provide pre-exposure and post-exposure prophylaxis.

Logo Rabies Vaccine BP

Rabies vaccine ≥ 2.5 IU/ml (inactivated)

 

Presentation

1 ml prefilled diluent syringe + vial of lyophilised powder
Available in 1 vial
+ 1 syringe packs

Schedule

Pre-exposure prophylaxis:

3 doses at 0, 7 and 21 or 28 days.
Special population – immunocompromised individuals: serology testing 2-4 weeks after vaccination to assess the need for additional doses.

Post-exposure prophylaxis:
- In previously immunised individuals: two further boosters should be given, one on day 0 and one on day 3.
- In previously non-immunised individuals: the first injection of rabies vaccine (day 0) should be given as soon as possible after the suspected contact and followed by four further doses on days 3, 7, 14, and 28.
Special population – immunocompromised individuals: only a full vaccination schedule should be administered. Rabies immunoglobulin as per local official recommendations.

 

Further doses

For those at continued risk, booster doses should be given in line with official recommendations.

Age range

No lower or upper age limit listed

 

References:

  1. http://www.fitfortravel.nhs.uk/advice/disease-prevention-advice/rabies Accessed August 2020
  2. WHO Rabies Fact sheet. http://www.who.int/en/news-room/fact-sheets/detail/rabies Accessed August 2020
  3. National Travel Health Network and Centre (NaTHNaC). Travel Health Pro – Factsheet: Rabies. Available at: http://travelhealthpro.org.uk/factsheet/20/rabies Accessed August 2020

RABIES VACCINE BP SmPC

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

Rabies Vaccine BP Prescribing information

View the Rabies Vaccine BP SmPC

Materials Ordering Online – Giving You Access to A Range Of Support Materials

Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.

• Simply visit https://sanofi.medisa.com

• Select the user group which best describes your role in your organisation

• Narrow your search by selecting the appropriate disease area

• Select which materials you would like to receive and how many

• Log-in or register to create an account

• Confirm your order

VISIT MEDISA

 

Date of preparation: September 2020 | MAT-GB-2001793(v2.0)